ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,752, issued on Aug. 11, was assigned to CILAG GMBH INTERNATIONAL (Zug, Switzerland).

"Multispecific antibodies having specificity for IL-4R and IL-31, encoding nucleic acids thereof and methods of treating" was invented by Julia Tietz (Schlieren, Switzerland), Tea Gunde (Zurich), Maria Johansson (Denges, Switzerland), Stefan Warmuth (Au, Switzerland), Alexandre Simonin (Rosenau, France), Christian Hess (Zurich), Noriko Shiraishi (Tokyo), Yoshio Arakawa (Tokyo) and Yoshihide Miyake (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a multispecific antibody comprising one or two binding domains, which specifically b...